Understanding Disparities in Lipid Management Among Patients with Type 2 Diabetes: Gender Differences in Medication Nonadherence after Treatment Intensification

Abstract Background Gender differences in dyslipidemia are widely documented, but the contributors to these differences are not well understood. This study examines whether differences in quality of care, intensity of lipid-lowering medication regimen, and medication adherence can explain this dispa...

Full description

Saved in:
Bibliographic Details
Published in:Women's health issues 2015, Vol.25 (1), p.6-12
Main Authors: Billimek, John, PhD, Malik, Shaista, MD, PhD, Sorkin, Dara H., PhD, Schmalbach, Priel, PhD, Ngo-Metzger, Quyen, MD, MPH, Greenfield, Sheldon, MD, Kaplan, Sherrie H., PhD, MPH
Format: Article
Language:English
Subjects:
Adult
Aged
Anticholesteremic Agents - therapeutic use
Blood Glucose
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Cross-Sectional Studies
Diabetes Complications - blood
Diabetes Complications - drug therapy
Diabetes Complications - ethnology
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - ethnology
Female
Hispanic or Latino - statistics & numerical data
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hyperlipidemias - blood
Hyperlipidemias - complications
Hyperlipidemias - drug therapy
Hyperlipidemias - ethnology
Hypertension - blood
Hypertension - complications
Hypertension - ethnology
Male
Medication Adherence - ethnology
Middle Aged
Obstetrics and Gynecology
Quality of Health Care
Sex Characteristics
Sex Distribution
Surveys and Questionnaires
Treatment Outcome
United States - epidemiology
White People - statistics & numerical data
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Gender differences in dyslipidemia are widely documented, but the contributors to these differences are not well understood. This study examines whether differences in quality of care, intensity of lipid-lowering medication regimen, and medication adherence can explain this disparity. Methods Secondary analysis of medical records data and questionnaires collected from adult patients with type 2 diabetes (n = 1,369) from seven outpatient clinics affiliated with an academic medical center as part of the Reducing Racial Disparities in Diabetes: Coached Care (R2D2C2) study. Primary outcome was low-density lipoprotein (LDL) cholesterol. Findings Women had higher LDL cholesterol levels than men (mean [SD], 101.2 [35.2] vs. 92.3 [33.0] mg/dL; p  
ISSN:1049-3867
1878-4321
DOI:10.1016/j.whi.2014.09.004